top of page

Our Top 5 Most Undervalued U.S. Stocks,
Using Our DDDD: (Deep Dive Due Diligence) 

A1 Financial's 5 top undervalued Nasdaq stocks in a chart

5 U.S. Stocks With 
Massive Upside Potential

Updated Feb 24th, 2026

 Let's begin by saying that any investment is risky.

Before investing in anything, do your own due diligence.  

Do not consider anything we, nor anyone else, writes as

financial advice. Only you can click the "Buy" button.

Also, please note this is not a "paid advertisement",

it is a free service we offer to our portfolio clients,

and share with our followers in the investing public on Social Media as well:

 

Simply Wall Street says LRHC's PT is $249.99 graphic
LRHC's EV graphic

#1 LRHC La Rosa Holdings Corp.

 EASILY the WILDEST Stock on Wall Street right now.

Wednesday it hit $2.26. It briefly hit $8 2 weeks ago.

Its 52 week range is .98 cents to $212.00!

This is why Simply Wall's $249.99 PT is not unreasonable.

 Sitting near the lowest point of that massive range, the 

company has greatly improved. Wednesday it bought the remaining half of a profitable RE Brokerage, without dilution, and now it sits at $1.09-- when it should have

closed around $4.

...It's like "OPPOSITE DAY" on Sponge Bob Square Pants.   

 Let's show why the two boxes above agree:

 On top is Simply Wall Street's analyst stating a future value per share owed to LRHC due to their Data Center investment.

The second is Yahoo Finance's stats, which means the share

price should be $13.22/sh, right now...And it's backed up:

 There have been BIG improvements at LRHC, from multiple recent PRs:

 La Rosa just reduced its cash burn 25%, eliminated $5.5 million in Convertible debt, reported $79 million in 2025 revenue, signed on to build a future cash cow Data Center in Florida, sold their majority Stake in LR Kissimmee Realty LLC for $500K eliminating the debt that debt weight caused, and

added an experienced Board member, who also sits on the 

board of RIME, which experienced a moon shot rise recently due to their cost saving logistics product. Yet --the share price closed Friday after hours at just $1.09 per share with only 159,720K shares floated.

What CRAZY planet is this? The company improved greatly and in just 4 weeks is 1/12 th of its intrinsic share price.

We figured there must be some dilution coming, so we checked--NONE is needed:

Per the dilution tracking site DilutionTracker.com:

 "The company has 20.9 months of cash left based on quarterly cash burn of -$2.08M and estimated current cash of $14.3M."...That's $26.73 per share in CASH ALONE.

$88.27 if you don't count restricted shares.

(The remaining OS is locked up, and owned by SZOP & insiders.)

Would you give a man at a flea market $1.09 for an old coin,

antique collectible, or anything else clearly worth $26.73?

Of course you would! Think of investing like flea market

"Megabuys", especially when they have low share floats: 

 LRHC boasts a tiny, tiny 159,270K float.

 This makes it a huge SHORT SQUEEZE candidate.

Finviz is reporting it at a ridiculous 43.23% Short Ratio.

The CTB numbers are in: a CTB Fee of 261.83% and a NEGATIVE REBATE FEE of -258.19%...

The short fees are nearly doubled, and the stock is clearly

1,200% past any reasonable bottom.

This is unheard of for a 159K nano float U.S. stock. 

 "China scam company" stocks do see this happen,

but never a quarterly reporting U.S. stock! -

Especially with:

$79 million in GROWING YoY revenue:

-Sales past 3/5Y UP 34.10% 

and

-EPS Q/Q UP 67%

Why this crazy low share price, then?

It's simply "Wreckless and Unwarranted Bear Activity", period.

They need to be punished severely.

LRHC is clearly a "No Brainer" #1 Most Undervalued stock.

It's WHY Simply Wall Street has posted a $249.99/sh PT,

Yahoo Finance shows the $13.72/sh EV

Finviz shows a $12.72/sh BV (will be over $19 when the

debt reduction updates)...and

Unrestricted cash alone is $26.73/sh to $88.27/sh. 

Curr=$1.09 PT =$26.73 (2,452% realistic short term upside potential...long term? 5,000% or more.)

(SimplyWallSt thinks 23,000% more!)

 With a SHORT SQUEEZE imminent on this tiny 159K float stock, this a wild ride, and an EASY:

Buy Button in green on computer 
keyboard

#2 ELAB  PMGC Holdings Inc.

 This tiny float (1.08M) stock company

PMGC Holdings Inc. last week filed an initial statement of beneficial ownership (Form 3) with the U.S. Securities and Exchange Commission. The filing identifies George Kovalyov, director of the company, purchased $19,600 in options...

They recently announced the completion of the acquisition of a $3+ per year manufacturing company, SVM Machining,

a Northern California-based ISO 9001:2015 Certified CNC precision machining and manufacturing services company serving medical, aerospace, biotech & pharmaceutical, semiconductor, and transportation markets.

 A PR last week was huge for an ELAB subsidiary:

"NorthStrive Biosciences Signs License Agreement for Commercialization of EL-22 and EL-32, a Myostatin-Engineered Probiotic for Muscle Preservation in Animal Health."​

 Headquartered in beautiful and affluent Newport Beach, CA,

this conglomerate is operating with a brilliant business plan.

Where would seem like "fracturing: to the old way of thinking,'

in today's economy what PMGC is doing is "bootstraping" with income producing subsidiaries, and income producing investments:

 They own 1,639,521 shares of CITR, purchased for around a $2.75 average per share, now worth around $7.33/share.

Earning about $8 million from just that.

 They have a list of parts, too, subsidiaries, mega cash, and their core company:

​

Subsidiary / Cash Valuation Table

--------------------------------------

Component Value w/ Per-Share Value

(Based on the 1.19M OS & 1.08K float:)

​

Cash (unrestricted) $15.5 M = $13.02/sh

AGA Precision Systems LLC =$0.20/sh

Pacific Sun Packaging Inc =$0.45/sh

CMC Aerospace =$0.25/sh

North Strive Bio Sciences = $.50/sh

PMGC Research Inc. =$0.15/sh

PMGC Capital LLC =$0.20/sh

CITR Ownership =$10.07/sh

SMV Manufacturing $3/sh

​

This above is not including the undisclosed stake in the nuclear company MMR. Anything "nuclear" nowadays has clear stock rocket potential, even just holdings.

-Aerospace contracts are rumored imminent now with the newly acquired ISO AS9100.

For small caps, this Certification achievement is RARE,

this PR was extremely under recognized as HUGE,

as LUCRATIVE Aerospace contracts can come at any moment.

Think of the recent "skyrocketing" successes of RKLB, ASTS, SIDU, LUNR, and others. SpaceX will be the largest IPO in history, said to be $30B or more...With a valuation of $1T to $1.5T.​

​​Curr $1.31 Our PT=$8.44 (Short term, but the actual value of cash, and subsidiaries at just face value is easily closer to Finviz's $45.64 BV. (632% realistic upside potential.)

​#3 SHPH Shuttle Pharmaceuticals 

SHPH has our attention with not only the bargain price of

under $2/sh, but ongoing events as well:-SHPH shot up like a space shuttle 400% in a previous Friday's pre-market trading...due to the 50% gioblastoma trial enrollment PR. The results from Phase 1 were astounding.-Also this recent PR: "Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer".-High "Insider Ownership" is always a very good sign, SHPH boasts 46.58% plus 5+% institutionally owned. SHPH also presented in Las Vegas in April. These two life and health enhancing companies have bright futures, and mathematically equal upsides...a first at A1.

A Reverse Split and offering were completed recently, so they're compliant and fully funded now.

 The recently acquired Molecule A.I. platform can be a game

changer in the fight against cancer, in which Shuttle has an even

greater chance now, of curing.

Curr=$1.06 PT =$6 (550% realistic upside potential.)

​

#4 IXHL Incannex Healthcare Inc.

The sequential, and almost concurrent PRs of "Incannex Reports Positive Topline Results from RePOSA Phase 2 Trial of IHL-42X" and "Incannex Confirms Strong Cash Position; No Plans or Requirement to Fully Utilize ATM in Near Term​"

and backing by this Benzinga article

"Nano-Cap Incannex's Sleep Apnea Candidate Shows Effectiveness And Safety In Mid-Stage Trial"

 PRs came just 48 days after another important PR: "Incannex Healthcare Cancels All Outstanding Series A Warrants". With a respectable 21.94% insider ownership, now solid balance sheet, gangbuster trial results, and clearly a dedicated following, this stock is now clearly QUITE undervalued. A "short squeeze" is in the cards, as Dark Pool greed will most likely backfire on the Bears.

 Curr=$.2853 =$1.13 (396% realistic upside potential.)​

​

#5 MGRX Mangoceuticals, Inc.

It was the clear cut WINNER (UP 48%) on news, and winner by volume (343.66 million shares traded) on Friday.

The company reported momentum for its $99-per-month injectable testosterone replacement therapy (TRT) program.

Since launching in mid-December, month-over-month sales for the injectable TRT program have climbed 336%, while customer acquisition costs have fallen 54%, the company said in an update.

Management expects TRT to be the primary growth driver as MangoRx expands both injectable and oral options, including its PRIME capsule, powered by Kyzatrex.

 Curr=$.5291 PT=$1.22 (230% realistic upside potential.)​​​

Forward-Looking Statements
Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Companies' current expectations and projections about future events that the Companies believe may affect its financial condition, results of operations, business strategy and financial needs. Shareholders can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "is/are likely to," "potential," "continue" or other similar expressions. The Companies undertake no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations that arise after the date hereof, except as may be required by law. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions, and other factors discussed in the "Risk Factors" section of the registration statements on Form S-1 filed with the SEC and other filings with the SEC. Although the Companies believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Companies cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Companies; registration statements and other filings with the SEC. Additional factors are discussed in the Companies' filings with the SEC, which are available for review at www.sec.gov.

Waiting Room

Copyright 2005-2026. All rights reserved. A1 Financial USA, and A1 Loans USA are the engines behind 
this website. We have been in business since 1990, happily serving our clients.

bottom of page